Merck | MRK - Cost Of Sales


Merck reported EUR2.27B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Adidas EUR 3.2B 20M Jun/2026
Adyen EUR 234.26M 7.61M Jun/2026
Akzo Nobel EUR 1.5B 95M Jun/2026
Alcon AG USD 1.12B 61M Jun/2026
Amadeus IT EUR 552M 37.5M Jun/2026
Amarin USD 26.05M 1.41M Dec/2025
AstraZeneca USD 2.52B 2.73B Jun/2026
BASF EUR 12.87B 1.01B Jun/2026
Bayer EUR 4.54B 692M Jun/2026
Beiersdorf EUR 2.06B 50M Dec/2025
Covestro EUR 2.7B 5.39B Dec/2025
Danone EUR 8.68B 1.95B Jun/2026
Fresenius EUR 4.4B 111M Jun/2026
Fresenius Medical Care EUR 3.55B 117.58M Jun/2026
Genmab DKK 84M 19M Jun/2026
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 2.07B 192M Jun/2026
GRIFOLS EUR 1.17B 90M Jun/2026
Henkel EUR 4.99B 37M Jun/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Infineon EUR 2.47B 129M Jun/2026
Lakefront Biotherapeutics EUR 9.14M 4.35M Jun/2026
Linde USD 4.52B 974M Mar/2026
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.27B 199M Jun/2026
Novartis USD 3.71B 251M Jun/2026
Philips EUR 2.21B 70M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Sanofi EUR 3.02B 656M Jun/2026
UCB EUR 1.07B 146M Dec/2025